Log in or Sign up for Free to view tailored content for your specialty!
Cutaneous Oncology News
Education increased sunscreen use among student athletes
An educational intervention targeting sunscreen use in student athletes was associated with improved sunscreen use.
IL-12 therapy elicits encouraging response rates in melanoma
Immunopulse IL-12 monotherapy and in combination with pembrolizumab was associated with encouraging response rates and safety data in patients with melanoma who may not respond to anti-PD-1 therapy, according to a press release.
Log in or Sign up for Free to view tailored content for your specialty!
Radial video mosaicing may aid in mapping lentigo maligna
Handheld reflectance confocal microscopy with radial video mosaicing showed utility in mapping lentigo maligna and lentigo maligna melanoma.
FDA grants breakthrough therapy designation to Tafinlar-Mekinist combination for adjuvant treatment of BRAF-positive melanoma
The FDA granted breakthrough therapy designation to the combination of dabrafenib and trametinib for adjuvant therapy of patients with stage III BRAF V600 mutation-positive melanoma, according to the agents’ manufacturer.
Post-transplant squamous cell carcinoma incidence declined in recent years
There has been a consistent decline in squamous cell carcinoma post-transplant among organ transplant recipients in Norway since the 1980s, according to recent findings.
One in five young women dependent on indoor tanning
Data from a recent survey demonstrate indoor tanning dependence was linked with symptoms of depression and beliefs about physical appearance.
FDA grants priority review to Opdivo for resected, high-risk melanoma
The FDA granted priority review to nivolumab for the treatment of patients with melanoma who are at high risk for disease recurrence following complete surgical resection, according to the drug’s manufacturer.
Residual atypical intraepidermal melanocytic proliferation may predict melanoma diagnosis
Increasing proportions of atypical intraepidermal melanocytic proliferation on various parts of the body may increase the likelihood of a diagnostic change to melanoma after Mohs micrographic surgery, according to findings presented at the American Society for Dermatologic Surgery Annual Meeting.
Upgrade to more aggressive subtype common in Mohs surgery patients
Patients undergoing Mohs micrographic surgery for aggressive subtypes of nonmelanoma skin cancer were frequently upgraded to a more aggressive subtype before the procedure, according to findings presented at the American Society for Dermatologic Surgery Annual Meeting.
USPSTF: Evidence lacking to determine benefits, harms of skin cancer self-exams
In a draft recommendation statement, the U.S. Preventive Services Task Force said there is insufficient evidence to determine if the benefits outweigh the harms from counseling adults about skin self-examinations for the prevention of skin cancer.
-
Headline News
‘Please talk about it’: Patients with heart disease want more guidance on sexual health
November 26, 20242 min read -
Headline News
Breast calcification on mammogram ‘especially predictive’ of CVD risk in younger women
November 26, 20243 min read -
Headline News
Q&A: How to talk to families about vaccines
November 26, 20245 min read
-
Headline News
‘Please talk about it’: Patients with heart disease want more guidance on sexual health
November 26, 20242 min read -
Headline News
Breast calcification on mammogram ‘especially predictive’ of CVD risk in younger women
November 26, 20243 min read -
Headline News
Q&A: How to talk to families about vaccines
November 26, 20245 min read